Parecoxib Impurity 6 Sodium Salt
|
帕瑞昔布雜質(zhì)6鈉鹽
|
198470-92-7
|
23-Hydroxy Budesonide (Mixture of Diastereomers)
|
23羥基布地奈德(雙立體異構(gòu)體的混合物)
|
109423-03-2
|
Lurasidone Impurity 64
|
魯拉西酮雜質(zhì)64
|
|
Rasagiline Impurity 18
|
雷沙吉蘭雜質(zhì)18對照品
|
1276516-73-4
|
6-beta-Hydroxy Lurasidone
|
6-β-羥基魯拉西酮
|
|
Moxifloxacin Impurity 6
|
莫西沙星雜質(zhì)6
|
|
Hydrocortisone Impurity 19
|
氫化可的松雜質(zhì)19
|
81968-66-3
|
Pantoprazole Magnesium Salt
|
泮托拉唑鎂鹽
|
1022083-88-0
|
Vonoprazan Impurity 73
|
沃諾拉贊雜質(zhì)73
|
|
Regorafenib Impurity 15
|
瑞戈非尼雜質(zhì)15
|
2098799-12-1
|
Regorafenib Impurity 9
|
瑞戈非尼雜質(zhì)9
|
|
Metoclopramide Impurity 3
|
甲氧氯普胺雜質(zhì)3
|
|
Paroxetine Impurity 30
|
帕羅西汀雜質(zhì)30
|
|
Pregabalin Impurity 65
|
普瑞巴林雜質(zhì)65對照品
|
|
Nintedanib Impurity 12 (Intedanib Impurity 12)
|
尼達尼布 雜質(zhì)12(阿達尼雜質(zhì)12)
|
|
Nintedanib Impurity 18 (Intedanib Impurity 18)
|
尼達尼布雜質(zhì)18(阿達尼雜質(zhì)18)
|
|
Regorafenib Impurity 18
|
瑞戈非尼雜質(zhì)18
|
|
Methylprednisolone EP Impurity J (Methylprednisolone Acetate, Methylprednisolone Hydrogen Succinate EP Impurity C)
|
甲基潑尼松EP雜質(zhì)J(醋酸甲基潑尼松龍、琥珀酸氫甲基潑尼龍EP雜質(zhì)C)
|
53-36-1
|
Vonoprazan Impurity 41
|
沃諾拉贊雜質(zhì) 41
|
928324-80-5
|
Parecoxib Impurity 30
|
帕瑞昔布雜質(zhì)30
|
181696-12-8
|
Aripiprazole Impurity 23
|
阿立哌唑雜質(zhì)23
|
|
Formoterol EP Impurity C (Mixture of Diastereomers)
|
福莫特羅EP雜質(zhì)C對照品
|
1795135-61-3
|
Formoterol EP Impurity I Trifluoroacetate
|
福莫特羅EP雜質(zhì)I三氟乙酸鹽對照品
|
532414-36-1
|
Hydrocortisone EP Impurity H
|
氫化可的松EP雜質(zhì)H
|
|
Ilaprazole Impurity 14
|
艾普拉唑雜質(zhì)14
|
|
Ilaprazole Impurity 15
|
艾普拉唑雜質(zhì)15
|
|
Indacaterol Impurity 16
|
茚達特羅雜質(zhì)16對照品
|
|
Moxifloxacin Impurity 21
|
莫西沙星雜質(zhì)21
|
|
Lenalidomide Impurity 3
|
來那度胺雜質(zhì)3
|
295357-66-3
|
Prednisolone Impurity 11 (Mixture of Z and E Isomers)
|
潑尼松龍雜質(zhì)11(Z和E異構(gòu)體的混合物)
|
115097-56-8
|
Fluticasone Furoate Impurity 5
|
糠酸氟替卡松雜質(zhì)5
|
|
Paliperidone Impurity 36
|
帕利哌酮雜質(zhì)36
|
1172995-13-9
|
Cortisone
|
可的松
|
|
Vonoprazan Impurity 26
|
沃諾拉贊雜質(zhì)26
|
|
Bisoprolol Fumarate EP Impurity S-13C6
|
富馬酸比索洛爾EP雜質(zhì)S-13C6
|
123-08-0
|
Methylprednisolone Acetate EP Impurity F
|
醋酸甲潑尼松EP雜質(zhì)F
|
|
Methylprednisolone Glucuronide
|
甲潑尼松葡糖苷酸
|
|
Pantoprazole Impurity 2
|
泮托拉唑雜質(zhì)2
|
|
Paroxetine Related Impurity 4
|
帕羅西汀相關(guān)雜質(zhì)4
|
|
Indacaterol Impurity 34
|
茚達特羅雜質(zhì)34對照品
|
|
Pregabalin Impurity 16
|
普瑞巴林雜質(zhì)16對照品
|
|
Nintedanib Impurity 26
|
尼達尼布雜質(zhì)26對照品
|
|
Nebivolol Impurity 24
|
奈比洛爾雜質(zhì)24
|
197706-50-6
|
Destrifluoroethoxy Lansoprazole
|
去三氟乙氧基蘭索拉唑
|
60524-97-2
|
Nebivolol Impurity 28 HCl (SS,RS)
|
Nebivolol Impurity 2 HCl (SR,RS)
|
920299-27-0
|
Moxifloxacin N-Sulfate Sodium Salt
|
莫西沙星N-硫酸鈉
|
|
Pregabalin Impurity 93
|
普瑞巴林雜質(zhì)93對照品
|
1488274-42-5
|
Parecoxib Impurity 55
|
帕瑞昔布雜質(zhì)55
|
198471-83-9
|
Febuxostat Impurity 69
|
非布司他雜質(zhì)69
|
|
Moxifloxacin Impurity 47
|
莫西沙星雜質(zhì)47
|
|
Lacosamide EP Impurity F (Lacosamide USP Related Compound F)
|
拉科酰胺EP雜質(zhì)F(酰胺USP相關(guān)化合物F)對照品
|
171623-02-2
|
21-Chloro Hydrocortisone
|
21氯氫化可的松
|
75868-48-3
|
Hydrocortisone Impurity 16
|
氫化可的松雜質(zhì)16
|
61774-28-5
|
Vonoprazan Impurity 15
|
沃諾拉贊雜質(zhì)15
|
|
Pantoprazole Impurity 40
|
泮托拉唑雜質(zhì)40
|
1261747-80-1
|
Procaterol Impurity 9
|
丙卡特羅雜質(zhì)9
|
|
Febuxostat Impurity 65
|
非布司他雜質(zhì)65
|
|
Lurasidone Impurity 4 DiHCl
|
魯拉西酮雜質(zhì)4 DiHCl
|
1260025-93-1
|
Pantoprazole N-Oxide
|
N-氧化泮托拉唑
|
953787-60-5
|
Famotidine Impurity 18
|
法莫替丁雜質(zhì)18
|
|
|
強的松
|
|
Lansoprazole Impurity 22
|
蘭索拉唑雜質(zhì)22
|
37699-43-7
|
Sorafenib related compound 37
|
索拉非尼相關(guān)化合物37
|
50528-86-4
|
Betamethasone Dipropionate EP Impurity H (6-alpha-Bromo Betamethasone Dipropionate)
|
倍他米松二丙酸EP雜質(zhì)H(6-α-溴倍他米松二丙酸)
|
|
Betamethasone Impurity 34
|
倍他米松雜質(zhì)34
|
|
Betamethasone Valerate Impurity G (beta-Bromo-Isomer)
|
戊酸倍他米松雜質(zhì)G(β-溴異構(gòu)體)
|
|
Landiolol Impurity 20
|
蘭地洛爾雜質(zhì)20
|
|
Piracetam Impurity 5 HCl
|
吡拉西坦雜質(zhì)5鹽酸鹽對照品
|
1096803-44-9
|
Ilaprazole Impurity 31
|
艾普拉唑雜質(zhì)31
|
|
Desoximetasone Impurity 15
|
去羥米松雜質(zhì)15
|
|
22R-6-beta-Hydroxy Budesonide
|
22R-6-β-羥基布地奈德
|
|
Moxifloxacin Impurity 103
|
莫西沙星雜質(zhì)103
|
1003709-67-8
|
5-beta-Dihydrocortisone
|
5-β-二氫可的松
|
68-54-2
|
Nebivolol Impurity 58
|
奈比洛爾雜質(zhì)58
|
|
6-beta Hydroxy Fludrocortisone
|
6-β-羥基氟氫可的松
|
806-36-0
|
Vonoprazan Impurity 56 HCl
|
沃諾拉贊雜質(zhì) 56鹽酸鹽
|
|
Lurasidone Impurity 57
|
魯拉西酮雜質(zhì)57
|
|
Aripiprazole Impurity 42
|
阿立哌唑雜質(zhì)42
|
|
Lenalidomide Impurity 49
|
來那度胺雜質(zhì)49
|
|
Olprinone Impurity 18
|
奧普力農(nóng)雜質(zhì)18
|
|
Hydrocortisone Impurity 10
|
氫化可的松雜質(zhì)10
|
|
Hydrocortisone Dimer Impurity 3
|
氫化可的松二聚體雜質(zhì)3
|
|
Hydrocortisone Impurity 23
|
氫化可的松雜質(zhì)23
|
|
Loxoprofen Impurity 22
|
洛索洛芬雜質(zhì)22
|
|
Paliperidone Impurity 17
|
帕利哌酮雜質(zhì)17
|
|
Febuxostat Impurity 55
|
非布司他雜質(zhì)55
|
2095166-41-7
|
Lurasidone Impurity 20
|
魯拉西酮雜質(zhì)20
|
|
Parecoxib Impurity 13
|
帕瑞昔布雜質(zhì)13
|
|
Nebivolol Impurity 4
|
奈比洛爾雜質(zhì)4
|
129050-29-9
|
Vonoprazan Impurity 17
|
沃諾拉贊雜質(zhì)17
|
|
11-epi-Prednisolone 21-Phosphate
|
11表潑尼松龍21磷酸鹽
|
|
Labetalol EP Impurity F HCl (Labetalol USP Related Compound F)
|
拉貝洛爾EP雜質(zhì)F HCl(拉貝洛爾USP相關(guān)化合物F)
|
96441-14-4
|
Fluticasone Impurity 49
|
氟替卡松雜質(zhì)49
|
192191-46-1
|
rac-Duloxetine Oxalate
|
rac度洛西汀草酸鹽
|
116817-14-2
|
Febuxostat Impurity 86
|
非布司他雜質(zhì)86
|
923942-36-3
|
Formoterol Impurity 47
|
福莫特羅雜質(zhì)47對照品
|
70284-07-0
|
Prednisolone 21-Ethylcarbonate
|
潑尼松21碳酸乙酯
|
|
Salmeterol EP Impurity B
|
沙美特羅EP雜質(zhì)B對照品
|
94749-02-7
|
Nintedanib Impurity 28
|
尼達尼布雜質(zhì)28對照品
|
855860-75-2
|
21-Deoxy Cortisone
|
21脫氧皮質(zhì)醇
|
1882-82-2
|